TMEM106B Polyklonaler Antikörper

• Featured Product
• KD/KO Validated

TMEM106B Polyklonal Antikörper für WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, IF, ELISA

Konjugation

Unkonjugiert

Publikationen

7

Rezensionen (1)

Kat-Nr. : 20995-1-AP

Synonyme

TMEM106B, transmembrane protein 106B

---

Galerie der Validierungsdaten

• 

  WB analysis using 20995-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 20995-1-AP (TMEM106B antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HeLa using 20995-1-AP

  WB result of TMEM106B antibody (20995-1-AP; 1:2000; incubated at room temperature for 1.5 hours) with sh-Control and sh-TMEM106B transfected HeLa cells.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: A549-Zellen, HeLa-Zellen, HepG2-Zellen

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:500-1:2000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• WB: See 4 publications below
• IHC: See 1 publications below
• IF: See 3 publications below

Produktinformation

20995-1-AP bindet in WB, IHC, IF, ELISA TMEM106B und zeigt Reaktivität mit human, Maus

• Getestete Reaktivität: human, Maus
• In Publikationen genannte Reaktivität: human, Maus
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: TMEM106B fusion protein Ag14264
• Vollständiger Name: transmembrane protein 106B
• Berechnetes Molekulargewicht: 31 kDa
• Beobachtetes Molekulargewicht: 31-35 kDa, 40-55 kDa
• GenBank-Zugangsnummer: BC033901
• Gene symbol: TMEM106B
• Gene ID (NCBI): 54664
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

TMEM106B is a genetic risk factor for frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP). Amyotrophic lateral sclerosis (ALS), like FTLD-TDP, is characterized by pathological TDP-43 inclusions. TMEM106B expression in the brain may be linked to mechanisms of disease in FTLD-TDP and risk alleles confer genetic susceptibility by increasing gene expression. TMEM106B can be showed as 31-55 kDa and 70-90 kDa (Glycosylated or Dimer) form in western blot test. (PMID: 27543298, 22895706, PMID: 23136129).

Publikationen

Species	Application	Title
human	IHC	Cell; Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.; Authors - Andrew Chang
human	WB	J Neurosci; TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.; Authors - Chen-Plotkin Alice S AS
human	WB	Alzheimers Res Ther; TMEM106B expression is reduced in Alzheimer's disease brains.; Authors - Jun-Ichi Satoh
mouse	IF	Mol Brain; TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.; Authors - Mi-Hee Jun
human	WB	PLoS One; Construction of ceRNA network to identify the lncRNA and mRNA related to non-small cell lung cancer.; Authors - Kui Xiao
human	IF	Sci China Life Sci; Superresolution live-cell imaging reveals that the localization of TMEM106B to filopodia in oligodendrocytes is compromised by the hypomyelination-related D252N mutation; Authors - Shijia Xing

Rezensionen

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.

---

FH

Carolyn (Verified Customer) (02-18-2022)

good signal, low background

• Applications: Western Blot
• Primary Antibody Dilution: 1:1000
• Cell Tissue Type: Human brain tissue extract